Author

Ron Saad

Tel Aviv University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:statistical model· 4 Assay:bulk RNA-seq· 3 Research Focus:differential expression· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Uri Ben‐DavidiD· 4 shared Haia Khoury· 2 shared Amjad Zoabi· 1 shared Andrew McCaffreyiD· 1 shared Daniela CiminiiD· 1 shared Daniella S. McCauslandiD· 1 shared Einav Someach· 1 shared Eran SdeoriD· 1 shared

Activity by Year

2025-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

Uri Ben‐DavidORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Genomic fidelity and evolution of cancer patient-derived organoids

Linoy Raz, Haia Khoury, Tal Ben-Yishay, Ron Saad, Amjad Zoabi, Giulia Orlandi, Sara Donzelli, Giovanni Blandino, Uri Ben-David

This study evaluates genomic stability and evolution in cancer patient-derived organoids across 16 cancer types, finding higher genomic fidelity compared to patient-derived xenografts.

bioRxiv · Jul 8, 2026 · PreprintCancer Biology

Pan-cancer analysis of single-cell RNA sequencing data from 304 human tumors sheds light on the aneuploidy paradox

Guy Wolf-Dankovich, Tomer Mashiah, Ron Saad, Einav Someach, Haia Khoury, Itay Tirosh, Uri Ben‐David

This study analyzes single-cell RNA sequencing data from 304 tumors to explore how aneuploidy affects cancer progression and cellular fitness.

bioRxiv · May 11, 2026 · PreprintCancer Biology

Cell and nuclear size are associated with chromosomal instability and tumorigenicity in cancer cells that undergo whole genome doubling

Mathew Bloomfield, Sydney M Huth, Daniella S. McCausland, Ron Saad, Nazia Bano, Tran N. Chau, Megan L. Sweet, Nicolaas C. Baudoin, Andrew McCaffrey, Kai Fluet, Eva M. Schmelz, Uri Ben‐David, Daniela Cimini

The paper shows that cell and nuclear size in tetraploid cancer cells correlate with chromosomal instability and tumorigenicity, with smaller cells having better fitness and poorer patient survival in WGD-positive cancers.

Cancer Research · Jan 22, 2026Peer-reviewedCancer Biology

Chromosome-arm 17p Loss Renders Breast Cancer Cells Vulnerable to AURKB Inhibition

Tom Winkler, Eran Sdeor, Ron Saad, Hajime Okada, Kathrin Laue, Gil Leor, Guy Wolf, Shlomit Strulov Shachar, Uri Ben‐David

This study identifies Del17p as a biomarker for AURKB inhibition in breast cancer, showing increased sensitivity to AURKB inhibitors in Del17p tumors.

bioRxiv · Dec 2, 2025 · PreprintCancer Biology

Integrating gene expression, mutation and copy number data to identify driver genes of recurrent chromosome-arm losses

Ron Saad, Ron Shamir A, Uri Ben‐David

The paper identifies 311 candidate driver genes for recurrent chromosome-arm losses in 20 cancer types using integrated gene expression, mutation, and copy number data from ~7,500 tumors.

Cell Reports · Oct 23, 2025Peer-reviewedCancer Biology